EFHD2 and non-small cell lung carcinoma: In this study, we found that coclaurine, a compound in S. tetrandra, effectively sensitizes NSCLC cells to cisplatin and also inhibits tumorigenesis and stemness characteristics in NSCLC cells, suggesting that coclaurine may serve as a lead compound for developing EFHD2 inhibitors.